537 related articles for article (PubMed ID: 30614282)
21. The effects of myo-inositol vs. metformin on the ovarian function in the polycystic ovary syndrome: a systematic review and meta-analysis.
Azizi Kutenaei M; Hosseini Teshnizi S; Ghaemmaghami P; Eini F; Roozbeh N
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3105-3115. PubMed ID: 33877679
[TBL] [Abstract][Full Text] [Related]
22. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Adv Ther; 2024 Jun; 41(6):2168-2195. PubMed ID: 38683294
[TBL] [Abstract][Full Text] [Related]
24. Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article.
Wang J; Zhu L; Hu K; Tang Y; Zeng X; Liu J; Xu J
Medicine (Baltimore); 2017 Sep; 96(39):e8183. PubMed ID: 28953677
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of thiazolidinediones and metformin for polycystic ovary syndrome.
Du Q; Wang YJ
Saudi Med J; 2012 Sep; 33(9):954-61. PubMed ID: 22964806
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
Fruzzetti F; Perini D; Russo M; Bucci F; Gadducci A
Gynecol Endocrinol; 2017 Jan; 33(1):39-42. PubMed ID: 27808588
[TBL] [Abstract][Full Text] [Related]
27. Effects of acarbose on polycystic ovary syndrome: a meta-analysis.
Zhang YY; Hou LQ; Zhao TY
Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):373-8. PubMed ID: 24941435
[TBL] [Abstract][Full Text] [Related]
28. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
Regidor PA; Schindler AE; Lesoine B; Druckman R
Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
[TBL] [Abstract][Full Text] [Related]
29. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis.
Han Y; Li Y; He B
Reprod Biomed Online; 2019 Aug; 39(2):332-342. PubMed ID: 31229399
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis.
Zeng L; Yang K
Endocrine; 2018 Jan; 59(1):30-38. PubMed ID: 29052180
[TBL] [Abstract][Full Text] [Related]
31. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome.
Nazirudeen R; Sridhar S; Priyanka R; Sumathi B; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
Clin Endocrinol (Oxf); 2023 Aug; 99(2):198-205. PubMed ID: 37265016
[TBL] [Abstract][Full Text] [Related]
33. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
34. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
[TBL] [Abstract][Full Text] [Related]
35. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
Xing C; Li C; He B
J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
[TBL] [Abstract][Full Text] [Related]
36. Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis.
Hu Y; Song X; Hamiti S; Ma Y; Yusufu M; Wang X; Zhang K; Guo Y
BMC Endocr Disord; 2023 Nov; 23(1):250. PubMed ID: 37974132
[TBL] [Abstract][Full Text] [Related]
37. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
[TBL] [Abstract][Full Text] [Related]
38. Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome.
Fruzzetti F; Fidecicchi T; Palla G; Gambacciani M
Gynecol Endocrinol; 2020 Feb; 36(2):152-155. PubMed ID: 31317814
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS].
Cappelli V; Di Sabatino A; Musacchio MC; De Leo V
Minerva Ginecol; 2013 Aug; 65(4):425-33. PubMed ID: 24051942
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy between NAC and metformin in treating PCOS patients: a meta-analysis.
Song Y; Wang H; Huang H; Zhu Z
Gynecol Endocrinol; 2020 Mar; 36(3):204-210. PubMed ID: 31749393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]